nivasorexant   Click here for help

GtoPdb Ligand ID: 12719

Synonyms: ACT-539313 | ACT539313
Compound class: Synthetic organic
Comment: Nivasorexant an orally active, selective and reversible orexin OX1 receptor antagonist (1-SORA). The chemical structure for nivasorexant matches that for Idorsia Pharmaceuticals' former clinical lead ACT-539313 [1]. ACT-539313's discovery was disclosed in February 2024 [2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 0
Rotatable bonds 6
Topological polar surface area 85.46
Molecular weight 429.48
XLogP 3.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC=C(C(=C1)N2N=CC=N2)C(=O)N3CCOC[C@H]3CC4=CC=CC(=C4)N5N=CC=N5
Isomeric SMILES CC1=CC(=C(C=C1)C(=O)N2CCOC[C@H]2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5
InChI InChI=1S/C23H23N7O2/c1-17-5-6-21(22(13-17)30-26-9-10-27-30)23(31)28-11-12-32-16-20(28)15-18-3-2-4-19(14-18)29-24-7-8-25-29/h2-10,13-14,20H,11-12,15-16H2,1H3/t20-/m1/s1
InChI Key GKPHAIOJCHBZCT-HXUWFJFHSA-N
Bioactivity Comments
Apparent equilibrium dissociation constant (Kb) for ACT‐539313 is 0.69 nM vs. OX1 and 42 nM vs. OX2 [1]. Its potency at non-human mammalian orexin receptors is similar to its potency at the human receptors.